About
Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative PCR”, “first-generation Sanger sequencing”, “second-generation high-throughput NGS sequencing” and “capillary electrophoresis”. "Fragment Analysis" and "Chemiluminescence CLIA" five molecular diagnostic technology platforms, we will be based on clinical diagnosis and treatment needs to develop molecular diagnostic products based on the above technology platform.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 1,530 investors are based in Beijing, Beijing, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Beijing, China
Contact Information
linkedin.com/in/••••••••
Find more investors like GenomePrecision
Search Investors